Fig. 2From: Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United StatesActions taken to address AEs occurring during treatment with ARI among subset of patients with ≥1 AEa. Abbreviations: AE, adverse event; ARI, androgen receptor inhibitor. a Actions taken to address AEs are not mutually exclusive; multiple actions could have been takenBack to article page